A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Lensar, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 700 shares of LNSR stock, worth $4,956. This represents 0.0% of its overall portfolio holdings.

Number of Shares
700
Previous 500 40.0%
Holding current value
$4,956
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.99 - $5.44 $80,466 - $109,708
-20,167 Reduced 83.56%
3,967 $18,000
Q2 2024

Aug 14, 2024

BUY
$3.0 - $4.88 $47,427 - $77,147
15,809 Added 189.9%
24,134 $108,000
Q1 2024

May 15, 2024

SELL
$3.25 - $5.0 $5,729 - $8,815
-1,763 Reduced 17.48%
8,325 $28,000
Q4 2023

Feb 14, 2024

BUY
$2.01 - $3.51 $2,263 - $3,952
1,126 Added 12.56%
10,088 $35,000
Q3 2023

Nov 14, 2023

BUY
$3.02 - $4.45 $27,065 - $39,880
8,962 New
8,962 $27,000
Q1 2023

May 15, 2023

BUY
$2.19 - $3.27 $32,858 - $49,063
15,004 New
15,004 $37,000

Others Institutions Holding LNSR

About LENSAR, Inc.


  • Ticker LNSR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 11,021,000
  • Market Cap $78M
  • Description
  • LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...
More about LNSR
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.